Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to helping patients live better. Blue Note is merging deep scientific and clinical expertise with digital and gaming ideas to transform care for seriously ill patients. Working closely with leading medical researchers and patient advocacy organizations, Blue Note is creating clinically validated, FDA-approvable, and prescription-only digital devices to treat the burden of illness. The company was founded in 2018 and is based in San Francisco, California.

The first digital therapeutic in oncology for patients and their care teams.

Cancer-related distress, which can be defined as any unpleasant feeling, emotion, or experience that affects a cancer patient’s quality of life or ability to cope with cancer diagnosis and treatment, affects millions of people. Fewer than half of those who experience cancer-related distress have access to the mental health care they need to find relief. Blue Note Therapeutics is working to close this gap.

SYMPTOM MANAGEMENT

The evidence-based algorithms and qualifying questions within Oleena® evaluate each symptom reported in order to give personalized recommendations.

PROGRESS MONITORING

Oleena® continues monitoring the patient until the symptom subsides, while adapting the recommendations according to how the symptom evolves.

HELPFUL RESOURCES

Patients have access to detailed information and resources within the app – both to better understand their own symptoms and learn more about cancer care in general.